Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain

Reported by Yahoo Finance · Published 13 Sep 2026, 12:57 AM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Nigel Farage’s Reform UK lands $97 million donations from two crypto billionaires in 24 hours 16 min ago Anthropic CEO calls for AI race to slow down. Musk and OpenAI's Altman agrees 23 min ago Larry Ellison cancels plan to sell Oracle stock 29 min ago How Concerned Should Income Investors Be About Pfizer's Dividend? 32 min ago GameStop Billionaire Ryan Cohen Buys 1 Million Shares for $20 Million. What This Large Purchase Means for GME 34 min ago 'Skimpflation' warning as tinned mackerel alternative hits more supermarket shelves 36 min ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain

Summary

More in Markets

How Concerned Should Income Investors Be About Pfizer's Dividend?

GameStop Billionaire Ryan Cohen Buys 1 Million Shares for $20 Million. What This Large Purchase Means for GME

Hershey’s Dividend Is Finally Growing Again After a Nearly 2-Year Freeze

Ford Motor vs. General Motors: Which Automotive Stock Is a Better Buy in 2026?

Worried About RMDs in Retirement? 3 Key Moves to Lower the Hassle Factors.

He Spent Down the Roth First to ‘Save’ the IRA for His Kids. He Left Them a $120,000 Tax Bill Instead of a Tax-Free Account